We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NYT:NYSENew York Times Company (The) Analysis

Data as of 2026-08-21 - not real-time

$65.69

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The New York Times Company is priced at $65.69 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 12.4% over the past 30 days. Relative strength is 40.5 — neutral — and the MACD signal is bearish. The recent range runs from support at $63.05 up to resistance at $78.04.
The shares look overvalued, trading on 27.4 times earnings above a sector average of 16.1. Consensus targets land 18.2% above where the shares trade now. Revenue is growing at 11.3% on a 13.3% profit margin. The 1.41% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 51.1%, a beta of 0.11 and a maximum drawdown of 26.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 2/10 conviction over the longer horizon.

Top Market Events

Newspaper and digital media company The New York Times NYSE:NYT reported Q2 CY2026 results , with sales up 11.Seeking Alpha16dNew York Times slips after Q2 earnings beat amid margin concernsShares of The New York Times Company...Yahoo Finance16dNew York Times Co NYT Q2 2026 Earnings Call Highlights: Digital Subscriptions and .

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 73.22
  • MACD momentum is negative

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 27.4 versus sector average of 16.1
  • Trading below the 200-day average of 73.22

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 27.4 versus sector average of 16.1
  • Analyst targets imply +18.2% versus the current price
  • Revenue growth of +11.3%

Key Metrics & Analysis

Financial Health

Revenue Growth11.30%
Profit Margin13.31%
P/E Ratio27.4
ROE19.72%
ROA10.39%
P/B Ratio5.2
Op. Cash Flow$658.3M
Free Cash Flow$459.9M
Industry P/E16.1

Technical Analysis

TrendBearish
RSI40.5
Support$63.05
Resistance$78.04
MA 20$68.47
MA 50$71.28
MA 200$73.22
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

Fair Value$62.72
Target Price$77.67
Upside/Downside18.23%
GradeOvervalued
TypeBlend
Dividend Yield1.41%

Risk Assessment

Beta0.11
Volatility51.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.